We are thrilled to welcome Dr. Wechsler to our Board of Directors,” said Dr. Carl Goldfischer, Chair of the Board of Galecto. “Amy is a distinguished physician who has board certification in both ...

Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...

Mit aller Härte, die der Vater für nötig hält und die ihm selbst widerfahren ist, erzieht er den Sohn zum Hoferben. Doch der ...

Dovid Efune is in exclusive negotiations to acquire the UK's Telegraph for $550 million. Rachel Reeves has reduced the ...

After kicking off a sales process roughly a month ago, eye-health firm Bausch + Lomb has stirred up significant interest from ...

It was quite a busy and eventful day for the company.

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

Private equity firms TPG and Blackstone are working on a potential deal to buy Brent Saunders-led eye care company Bausch + ...

Longboard Pharmaceuticals, Inc. LBPH shares jumped 51.2% to $58.83 after the company announced it will be acquired by Lundbeck. Upstart Holdings, Inc. UPST climbed 16.6% to $54.86 after Wedbush ...

Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company ...

Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity ...